FTH
SENSEI BIOTHERAPEUTICS INC
$16.65
+14.59%
$23.9M
No data for this timeframe.
Vol
Market Cap$23.9M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (80%)
Inst. Holders1 funds
Inst. Value$244.3K
Inst. Activity1 buys / 0 sells
Prev Close $14.53
Recent Activity
Jun 15, 2026
Insider
Hahn Stephen M. acquired 44,763 shares
Director
Jun 15, 2026
Insider
Hahn Stephen M. disposed of 44.763 shares
Director
Jun 15, 2026
Insider
Parikh Anand Kiran acquired 761,428 shares
President and CEO
Inst.
NATIONAL BANK OF CANADA — DOUBLED
45,575 shares ($27.3K)
Price Targets
$52.50
+194.6% upside
Strong Buy
Current $17.82
Low $50.00
Median $52.50
High $55.00
4 analysts
$50.00
$55.00
Analyst Ratings
4Strong Buy
4Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 15, 2026 | BTIG | REITERATE | Buy → Buy |
| Jun 11, 2026 | BTIG | INITIATE | Buy |
| May 29, 2026 | Cantor Fitzgerald | INITIATE | Overweight |
| May 28, 2026 | LUCID CAPITAL MARKETS | INITIATE | Buy |
| May 22, 2026 | Citigroup | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-5.45 ▼ -712.8% | $-10.07 — $-0.98 | -39% YoY | 4 |
| Next Q | $-5.67 ▼ -687.4% | $-10.44 — $-1.00 | -57% YoY | 4 |
| Current FY | $-104.31 ▼ -3665.6% | $-161.01 — $-20.08 | -524% YoY | 4 |
| Next FY | $-7.90 ▼ -109.6% | $-13.86 — $-3.97 | 92% YoY | 4 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $244.3K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 15, 2026 | Hahn Stephen | C | $0.00 |
| Jun 15, 2026 | Hahn Stephen | C | $0.00 |
| Jun 15, 2026 | Parikh Anand | C | $0.00 |
| Jun 15, 2026 | Parikh Anand | C | $0.00 |
| Jun 12, 2026 | Hahn Stephen | A | $0.00 |
1 institutional holders with $244.3K total value (7,750 shares) as of 2026-Q1. Top holders: VANGUARD.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 7,750 | $244.3K | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | DOUBLED | 10,000 | 45,575 | +355.8% | $27.3K | 2024-Q3 |
3 unique insiders with 8 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Hahn Stephen M. | Director | CONVERT | 44,763 | — | — |
| Jun 15, 2026 | Hahn Stephen M. | Director | CONVERT | 44.763 | — | — |
| Jun 15, 2026 | Parikh Anand Kiran | President and CEO | CONVERT | 761,428 | — | — |
| Jun 15, 2026 | Parikh Anand Kiran | President and CEO | CONVERT | 761.428 | — | — |
| Jun 12, 2026 | Hahn Stephen M. | Director | AWARD | 25,000 | — | — |
| Jun 12, 2026 | Ramasastry Saira | Director | AWARD | 25,000 | — | — |
| Feb 17, 2026 | Parikh Anand Kiran | President and CEO | AWARD | 12,320 | — | — |
| Feb 17, 2026 | Parikh Anand Kiran | President and CEO | AWARD | 761.428 | — | — |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (80% buy). Based on 10 analysts: 4 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$52.50 mean target
+194.6% upside
Strong Buy (1.00)
$50.00 Low
$55.00 High
| Metric | Value |
|---|---|
| Current Price | $17.82 |
| Target Low | $50.00 |
| Target Mean | $52.50 |
| Target Median | $52.50 |
| Target High | $55.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-5.45 | $-10.07 | $-0.98 | -39.3% | -712.8% | — | $0.0B | 0.0% | 4 |
| Next Q 2026-09-30 |
$-5.67 | $-10.44 | $-1.00 | -56.6% | -687.4% | — | $0.0B | 0.0% | 4 |
| Current FY 2026-12-31 |
$-104.31 | $-161.01 | $-20.08 | -523.8% | -3665.6% | — | $0.0B | 0.0% | 4 |
| Next FY 2027-12-31 |
$-7.90 | $-13.86 | $-3.97 | 92.4% | -109.6% | 2↑ 0↓ | $0.0B | 0.0% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-5.446 | |
| 7d ago | $-3.905 | -1.541 |
| 30d ago | $-0.670 | -4.776 |
| 60d ago | $0.000 | -5.446 |
| 90d ago | $0.000 | -5.446 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 4 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 15, 2026 | BTIG | REITERATE | Buy | Buy |
| Jun 11, 2026 | BTIG | INITIATE | — | Buy |
| May 29, 2026 | Cantor Fitzgerald | INITIATE | — | Overweight |
| May 28, 2026 | LUCID CAPITAL MARKETS | INITIATE | — | Buy |
| May 22, 2026 | Citigroup | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 4 | 2 | 0 | 0 | 80% | |
| May 1, 2026 | 3 | 3 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.